N-Nitroso Edoxaban Impurity 4
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs .N-Nitroso Edoxaban Impurity 4 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 4 chemically represented as 2-bromo-5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridine . Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 4 .We supply N-Nitroso Edoxaban Impurity 4 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-E39209 |
| CAS No | 2803476-80-2 |
| Mol.F. | C9H9ClN2O3 |
| Mol.Wt. | 228.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39210 |
| CAS No | 349125-08-2 |
| Mol.F. | C9H9ClN2O3 : HCl |
| Mol.Wt. | 228.6 : 36.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39211 |
| CAS No | 45644-21-1 |
| Mol.F. | C5H5ClN2 |
| Mol.Wt. | 128.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39212 |
| CAS No | 2081883-52-3 |
| Mol.F. | C14H27N3O3 |
| Mol.Wt. | 285.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39213 |
| CAS No | 2733729-72-9 |
| Mol.F. | C16H22ClN5O3 |
| Mol.Wt. | 367.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39214 |
| CAS No | 165948-23-2 |
| Mol.F. | C6H8N2S |
| Mol.Wt. | 140.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39215 |
| CAS No | 4214-74-8 |
| Mol.F. | C5H4Cl2N2 |
| Mol.Wt. | 163g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39216 |
| CAS No | 365998-35-2 |
| Mol.F. | C22H33N3O5 |
| Mol.Wt. | 419.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39217 |
| CAS No | 365997-36-0 |
| Mol.F. | C15H27NO7S |
| Mol.Wt. | 365.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39218 |
| CAS No | 365997-34-8 |
| Mol.F. | C14H24N4O4 |
| Mol.Wt. | 312.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39219 |
| CAS No | 2760449-95-2 |
| Mol.F. | C9H19N3O : 2(HCl) |
| Mol.Wt. | 185.3 : 2(36.5)g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39220 |
| CAS No | 365997-67-7 |
| Mol.F. | C12H20N4O4 |
| Mol.Wt. | 284.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39221 |
| CAS No | 365998-33-0 |
| Mol.F. | C22H32N2O6 |
| Mol.Wt. | 420.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39222 |
| CAS No | 2408469-02-1 |
| Mol.F. | C9H9Cl3N2OS |
| Mol.Wt. | 299.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39223 |
| CAS No | NA |
| Mol.F. | C26H37ClN4O3 |
| Mol.Wt. | 489.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39224 |
| CAS No | NA |
| Mol.F. | C25H37N7O3S2 |
| Mol.Wt. | 547.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |